Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: Results of an observational, health-related quality of life study in the UK

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Dominiak Felden, Géraldine ^a   Cohet, Catherine ^a   Atrux Tallau, Samantha ^a   Gilet, Hélène ^b   Tristram, Amanda ^c   Fiander, Alison ^c  

^a SANOFI PASTEUR   (France)

^b MAPI Institute   (France)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cervical neoplasia; Genital warts; HPV; Vaccination; Vulval disease

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; ARTICLE; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; MIDDLE AGED; MULTICENTER STUDY; PAPILLOMAVIRUS INFECTION; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SOCIOECONOMICS; UNITED KINGDOM; YOUNG ADULT;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; CONDYLOMATA ACUMINATA; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PSYCHOLOGICAL TESTS; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 84887300525     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-1065     Document Type: Article

References (47)

1. Epidemiology of genital human papillomavirus infection. Koutsky L, Am J Med 1997 102 3 8 (Pubitemid 127695953)
2. The causal relation between human papillomavirus and cervical cancer. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV, J Clin Pathol 2002 55 244 265 10.1136/jcp.55.4.244 11919208 (Pubitemid 34293391)
3. Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Lacey CJN, Lowndes CM, Shah KV, Vaccine 2006 24 Suppl 3 35 41
4. Papillomaviruses in human pathology: epidemiology, pathogenesis and oncogenic role. Wieland U, Pfister H, Human Papillomavirus Infection: A clinical Atlas Berlin: Ullstein Mosby, Gross GE, Barrasso R, 1997 1 18
5. New aspects of vulvar cancer: changes in localization and age of onset. Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG, Gynecol Oncol 2008 109 340 345 10.1016/j.ygyno.2008.01.041 18407339
6. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Jones RW, Baranyai J, Stables S, Obstet Gynecol 1997 90 448 452 10.1016/S0029-7844(97)00298-6 9277660 (Pubitemid 27357940)
7. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. Joura EA, Losch A, Haider-Angeler MG, Breitenecker G, Leodolter S, J Reprod Med 2000 45 613 615 10986677 (Pubitemid 30661117)
8. Trends in the incidence of invasive and in situ vulvar carcinoma. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA, Obstet Gynecol 2006 107 1018 1022 10.1097/01.AOG.0000210268.57527.a1 16648405
9. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Fenton KA, Lowndes CM, Sex Transm Infect 2004 80 255 263 10.1136/sti.2004.009415 15295121 (Pubitemid 39070785)
10. Health Protection Agency, STI Annual Data Tables [ http://www.hpa.org.uk/ Topics/InfectiousDiseases/InfectionsAZ/STIs/STIsAnnualDataTables/ ] Accessed 5-6-2013
11. Association between smoking and genital warts: longitudinal analysis. Hansen BT, Hagerup-Jenssen M, Kjaer SK, Munk C, Tryggvadottir L, Sparen P, Liaw KL, Nygard M, Sex Transm Infect 2010 86 258 262 10.1136/sti.2009.038273 20660589
12. Vulval intraepithelial neoplasia: current perspectives. Jones RW, Eur J Gynaecol Oncol 2001 22 393 402 11874067 (Pubitemid 34160722)
13. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, Bosch FX, de SS, Infect Agent Cancer 2012 7 38 10.1186/1750-9378-7-38 23273245
14. Chapter 1: HPV in the etiology of human cancer. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L, Vaccine 2006 24 Suppl 3 3-1-S310
15. A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Carter J, Sonoda Y, Baser RE, Raviv L, Chi DS, Barakat RR, Iasonos A, Brown CL, Abu-Rustum NR, Gynecol Oncol 2010 119 358 365 10.1016/j.ygyno.2010.07.016 20817227
16. Quality of life and sexual functioning after cervical cancer treatment: a long-term follow-up study. Greimel ER, Winter R, Kapp KS, Haas J, Psychooncology 2009 18 476 482 10.1002/pon.1426 18702067
17. The impact of cervical cancer on quality of life-the components and means for management. Herzog TJ, Wright JD, Gynecol Oncol 2007 107 572 577 10.1016/j.ygyno.2007.09.019 17963826 (Pubitemid 350160879)
18. Psychological distress and quality of life in cervical cancer survivors after radiotherapy: do treatment modalities, disease stage, and self-esteem influence outcomes? Kobayashi M, Ohno T, Noguchi W, Matsuda A, Matsushima E, Kato S, Tsujii H, Int J Gynecol Cancer 2009 19 1264 1268 10.1111/IGC. 0b013e3181a3e124 19820389
19. Health-related quality of life in cervical cancer survivors: a population-based survey. Korfage IJ, Essink-Bot ML, Mols F, Poll-Franse L, Kruitwagen R, van BM, Int J Radiat Oncol Biol Phys 2009 73 1501 1509 10.1016/j.ijrobp.2008.06.1905 18823716
20. Patients with genital warts have a decreased quality of life. Marra C, Ogilvie G, Gastonguay L, Colley L, Taylor D, Marra F, Sex Transm Dis 2009 36 258 260 10.1097/OLQ.0b013e318191a55e 19265737
21. The quality of life of patients with genital warts: a qualitative study. Mortensen GL, Larsen HK, BMC Public Health 2010 10 113 10.1186/1471-2458-10-113 20205944
22. Loss of quality of life associated with genital warts: baseline analyses from a prospective study. Sénécal M, Brisson M, Maunsell E, Ferenczy A, Franco EL, Ratnam S, Coutlee F, Palefsky JM, Mansi JA, Sex Transm Infect 2011 87 209 215 10.1136/sti.2009.039982 21335602
23. Estimation of the impact of genital warts on health-related quality of life. Woodhall S, Ramsey T, Cai C, Crouch S, Jit M, Birks Y, Edmunds WJ, Newton R, Lacey CJN, Sex Transm Infect 2008 84 161 166 10.1136/sti.2007.029512 18339658 (Pubitemid 351871484)
24. The impact of genital warts: loss of quality of life and cost of treatment in eight sexual health clinics in the UK. Woodhall SC, Jit M, Soldan K, Kinghorn G, Gilson R, Nathan M, Ross JD, Lacey CJN, Sex Transm Infect 2011 87 458 463 10.1136/sextrans-2011-050073 21636616
25. The role of illness perceptions: psychological distress and treatment-seeking delay in patients with genital warts. Ireland JA, Reid M, Powell R, Petrie KJ, Int J STD AIDS 2005 16 667 670 10.1258/095646205774357334 16212712 (Pubitemid 41527347)
26. Pilot study of sexual function and quality of life after excision for vulvar intraepithelial neoplasia. Likes WM, Stegbauer C, Tillmanns T, Pruett J, J Reprod Med 2007 52 23 27 17286063 (Pubitemid 46980021)
27. The prospective management of women with newly diagnosed vulval intraepithelial neoplasia: clinical outcome and quality of life. McFadden KM, Sharp L, Cruickshank ME, J Obstet Gynaecol 2009 29 749 753 10.3109/ 01443610903191285 19821671
28. The psychosocial impact of an abnormal cervical smear result. Drolet M, Brisson M, Maunsell E, Franco EL, Coutlee F, Ferenczy A, Fisher W, Mansi JA, Psychooncology 2012 21 1071 1081 10.1002/pon.2003 21695747
29. Psychosocial burden of abnormal pap smears among HIV-infected women at Chon Buri hospital, Thailand. Jayathunge MP, Bowanwatanuwong C, Maek A, Pitisuttithum BP, Southeast Asian J Trop Med Public Health 2010 41 224 234 20578502
30. Correlates of sexual function following vulvar excision. Likes WM, Stegbauer C, Tillmanns T, Pruett J, Gynecol Oncol 2007 105 600 603 10.1016/j.ygyno.2007.01.027 17306347 (Pubitemid 46734178)
31. Good Epidemiological Practice (GEP): IEA guidelines for proper conduct in epidemiological research. International Epidemiological Association (IEA), 2007 http://ieaweb.org/2010/04/good-epidemiological-practice-gep/
32. Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV. Mast TC, Zhu X, Demuro-Mercon C, Cummings HW, Sings HL, Ferris DG, Curr Med Res Opin 2009 25 2609 2619 19739938
33. Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts. Badia X, Colombo JA, Lara N, Llorens MA, Olmos L, Sainz de los Terreros M, Varela JA, Vilata JJ, Health Qual Life Outcomes 2005 3 24 10.1186/1477-7525-3-24 15817127 (Pubitemid 41522164)
34. Validation and clinical use of the CECA, a disease-specific quality of life questionnaire for patients with anogenital condylomata acuminata. Vilata JJ, Varela JA, Olmos L, Colombo JA, Llorens MA, de los Terreros MS, Badia X, Acta Derm Venereol 2008 88 257 262 18480925 (Pubitemid 351743869)
35. EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group, Health Policy 1990 16 199 208 10109801
36. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short-form (CSFQ-14). Keller A, McGarvey EL, Clayton AH, J Sex Marital Ther 2006 32 43 52 10.1080/00926230500232909 16234225
37. Psychological costs of inadequate cervical smear test results. French DP, Maissi E, Marteau TM, Br J Cancer 2004 91 1887 1892 10.1038/sj.bjc.6602224 15534608 (Pubitemid 40065516)
38. Kind P, Hardman G, Macran S, UK population norms for EQ-5D. Discussion paper 172. 1999 University of York Centre for Health Economics [ http://www.york.ac.uk/media/che/documents/papers/discussionpapers/ CHE%20Discussion%20Paper%20172.pdf ]. Accessed 12-1-2012
39. Incidence of anogenital warts in Germany: a population-based cohort study. Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E, BMC Infect Dis 2010 10 360 10.1186/1471-2334-10-360 21182757
40. The psychosocial burden of human papillomavirus related disease and screening interventions. Pirotta M, Ung L, Stein A, Conway EL, Mast TC, Fairley CK, Garland S, Sex Transm Infect 2009 85 508 513 10.1136/sti.2009.037028 19703844
41. The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions. Wang KL, Jeng CJ, Yang YC, Chen CA, Cheng WF, Chen TC, Mast TC, Wang YC, Hsieh CY, J Psychosom Obstet Gynaecol 2010 31 16 23 10.3109/01674820903564440 20121461
42. Short-term impact of cancer prevention and screening activities on quality of life. Cullen J, Schwartz MD, Lawrence WF, Selby JV, Mandelblatt JS, J Clin Oncol 2004 22 943 952 10.1200/JCO.2004.05.191 14990651 (Pubitemid 41103607)
43. Beliefs about Papanicolaou smears and compliance with Papanicolaou smear follow-up in adolescents. Kahn JA, Chiou V, Allen JD, Goodman E, Perlman SE, Emans SJ, Arch Pediatr Adolesc Med 1999 153 1046 1054 10.1001/archpedi.153.10. 1046 10520612 (Pubitemid 29473460)
44. The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Drolet M, Brisson M, Maunsell E, Franco EL, Coutlee F, Ferenczy A, Ratnam S, Fisher W, Mansi JA, Sex Transm Dis 2011 38 949 956 10.1097/OLQ.0b013e3182215512 21934571
45. Contribution of demographic, psychological and disease-related factors to quality of life in women with high-grade vulval intraepithelial neoplasia. Shylasree TS, Karanjgaokar V, Tristram A, Wilkes AR, MacLean AB, Fiander AN, Gynecol Oncol 2008 110 185 189 10.1016/j.ygyno.2008.04.023 18533238
46. The psychosocial impact of human papillomavirus infection: implications for health care providers. Clarke P, Ebel C, Catotti DN, Stewart S, Int J STD AIDS 1996 7 197 200 10.1258/0956462961917618 8799782 (Pubitemid 26191688)
47. Psychological burden of anogenital warts. Dediol I, Buljan M, Vurnek A, Bulat V, Itum A, Ubrilovia A, J Eur Acad Dermatol Venereol 2009 23 1035 1038 10.1111/j.1468-3083.2009.03242.x 19470067